Amyloid‐Related Imaging Abnormalities in the <scp>DIAN‐TU</scp>‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Nelly Joseph‐Mathurin(Mallinckrodt (United States)), Richard J. Perrin(Washington University in St. Louis), Nicole S. McKay(Mallinckrodt (United States)), Serge Gauthier(McGill University), Clifford R. Jack(Mayo Clinic), Karen C. Holdridge(Eli Lilly (United States)), Hiroyuki Shimada(Children's Hospital of Los Angeles), Mathias Jucker(TH Bingen University of Applied Sciences), Nick C. Fox(UK Dementia Research Institute), Sarah Berman(University of Pittsburgh Medical Center), Anne M. Fagan(Washington University in St. Louis), David Wallon(Centre Hospitalier Universitaire de Rouen), Ivonne Z. Jiménez‐Velázquez(University of Puerto Rico System), Johannes Levin(The University of Melbourne), Carlos Cruchaga(Washington University in St. Louis), Sandra E. Black(University College Dublin), Austin McCullough(Mallinckrodt (United States)), William S. Brooks(UNSW Sydney), Bret Borowski(Mayo Clinic in Florida), Carsten Hofmann(Roche (Switzerland)), Ging‐Yuek Robin Hsiung(University of British Columbia), Jason Hassenstab(Washington University in St. Louis), Jakub Wojtowicz(Roche (Switzerland)), Roger Clarnette(The University of Western Australia), Eric McDade(University of Pittsburgh), Catherine J. Mummery(University College London), Martin R. Farlow(MRC Laboratory of Molecular Biology), Diana A. Hobbs(Mallinckrodt (United States)), Guoqiao Wang(Washington University in St. Louis), Shaney Flores(Mallinckrodt (United States)), Michele Mancini(Eli Lilly (United States)), Gregory M. Preboske(Mayo Clinic in Arizona), Mario Masellis(Sunnybrook Health Science Centre), Charles D. Chen(Mallinckrodt (United States)), John M. Ringman(University of California, Los Angeles), Jasmeer P. Chhatwal(Harvard University), Kazushi Suzuki(National Defense Medical College), Russ C. Hornbeck(Mallinckrodt (United States)), Brian A. Gordon(Washington University in St. Louis), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Ethan Park(Washington University in St. Louis), Yan Li(Washington University in St. Louis), Qīng Wáng(Xuzhou Medical College), Gregory Klein(Roche (Switzerland)), R. Yaari(Eli Lilly (United States)), B. Joy Snider(Washington University in St. Louis), Thomas D. Bird(University of Washington), Neelum T. Aggarwal(Rush University Medical Center), Chengjie Xiong(Ludwig-Maximilians-Universität München), Lawrence S. Honig(Columbia University)
Cited by 42
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k